tiprankstipranks

Paul Schimmel Insider Profile

18 Followers
Paul Schimmel, Director at Alnylam Pharma, holds 1.10M shares in aTyr Pharma (Ticker: ATYR), holds 307.00K shares in Alnylam Pharma (Ticker: ALNY), holds ― shares in Forte Biosciences (Ticker: FBRX). Most recently, Paul Schimmel Bought ― shares of aTyr Pharma on Jul 24, 2024 for an estimated value of 184.40K.
tipranks
Paul Schimmel

Paul Schimmel
Alnylam Pharma (ALNY)
Director

Ranked #92,269 out of 99,635 Corporate Insiders

Profitable Transactions

20%
2 out of 10 Profitable Transactions

Average Return

-31.40%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$178M
54.69%
43.38%
1.93%
0.00%
A breakdown of Paul Schimmel's holdings

Insider Roles

Repligen
(RGEN)
Director
Alnylam Pharma
(ALNY)
Director
aTyr Pharma
(ATYR)
Director
Forte Biosciences
(FBRX)
Director
Roles that Paul Schimmel holds in companies

Most Profitable Insider Trade

Stock:
aTyr Pharma
(ATYR)
Rating:Informative Buy
Date:Jul 24, 2024 - Today
Return:+56.90%
The most profitable trade made by Paul Schimmel

Paul Schimmel's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Alnylam Pharma
Mar 14, 2018
Director
Uninformative Buy
1.37M
$77.05M
aTyr Pharma
Jul 24, 2024
Director
Informative Buy
184.40K
$3.44M
Forte Biosciences
Director
Repligen
Director
$97.15M
List of latest transactions for each holding click on a transaction to see Paul Schimmel's performance on stock

Paul Schimmel insider profile FAQ

What is the percentage of profitable transactions made by Paul Schimmel?
The percentage of profitable transactions made by Paul Schimmel is 20%.
    What is the average return per transaction made by Paul Schimmel?
    The average return per transaction made by Paul Schimmel is -31.40%.
      What stocks does Paul Schimmel hold?
      Paul Schimmel holds: ALNY, ATYR, FBRX, RGEN stocks.
        What was Paul Schimmel’s latest transaction?
        Paul Schimmel latest transaction was an Informative Buy of $184.40K.
          What was Paul Schimmel's most profitable transaction?
          Paul Schimmel’s most profitable transaction was an Informative Buy of ATYR stock on July 24, 2024. The return on the trade was 56.90%.
            What is Paul Schimmel's role in Alnylam Pharma?
            Paul Schimmel's role in Alnylam Pharma is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.